Substance Use Disorders Management Boot Camp In-Person Workshops (September 15-16, 2022)
This training aims to enhance confidence and competencies related to the management of substance use disorders in general medical settings. Through case-based and interactive didactic content, the workshop will explore issues related to assessment, monitoring, prevention, and management in the setting of unhealthy substance use.
Intended Audience
This program is designed for physicians, advanced practice nurses, and nurses who treat patients with opioid use disorder.
Learning Objectives
As a result of participating in this activity, learners will be able to:
- Determine accurate diagnosis and initiate treatment for OUD
- Determine accurate diagnosis and initiate treatment for AUD
- Interpret urine toxicology screens as it relates to treatment of opioid use disorder
- Demonstrate skills needed to to work with patients who continue to use drugs and alcohol while in treatment for opioid use disorder or alcohol use disorder
- Determine appropriate treatment plan for OUD, including the initiation and maintenance of buprenorphine therapy
- Determine appropriate treatment plan for AUD, including the initiation and maintenance of alcohol withdrawal management and medications for AUD
- Design clinic protocols for patient scheduling, rooming, triage calls, referrals to social work and behavioral health, and referral of complex patients for higher level of care
All times listed are Central Daylight Time
Thursday, September 15 | |
12:30 pm - 1:30 pm | Lunch & Welcome |
1:30 pm - 1:45 pm | Introductions & Waiver Training Information |
1:45 pm - 2:15 pm | Diagnosis & Evaluation |
2:15 pm - 3:15 pm | Alternative Initiation of Buprenorphine |
3:15 pm - 3:30 pm | Break (light refreshments) |
3:30 pm - 4:00 pm | Sublocade |
4:00 pm - 4:15 pm | Group Q&A |
4:!5 pm - 5:00 pm | Case Discussion (small groups) |
5:00 pm - 5:30 pm | Break |
5:30 pm - 7:00 pm | Reception |
Friday, September 16 | |
7:30 am - 8:30 am | Breakfast |
8:30 am - 10:00 am | Harm Reduction Services for People who Inject Drugs |
10:00 am - 10:15 am | Q&A |
10:15 am - 10:30 am | Break |
10:30 am - 11:45 am | Alcohol Content |
11:45 am - 12:15 pm | Small group case discussion |
12:15 pm - 1:00 pm | Lunch |
1:00 pm - 1:45 pm | Parallel Breakout Sessions
|
1:45 pm - 2:15 pm | Large group case discussion |
2:15 pm - 2:45 pm | Questions & Resources |
The conference will be held at The Osthoff Resort. Participants are responsible for booking their own transportation and lodging.
Policy on Disclosure
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.
For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation? |
Randy Brown | Course Director/Speaker | No relevant relationships with ineligible companies to disclose | Yes |
Kelly Eagen | Planner/Speaker | No relevant relationships with ineligible companies to disclose | No |
Jillian Landeck | Planner/Speaker | No relevant relationships with ineligible companies to disclose | No |
David Leinweber | Planner/Speaker | No relevant relationships with ineligible companies to disclose | No |
Kathleen Maher | Planner | No relevant relationships with ineligible companies to disclose | No |
Alison Miller | Planner/Speaker | No relevant relationships with ineligible companies to disclose | No |
Sara Scott | Accreditation Specialist | No relevant relationships with ineligible companies to disclose | No |
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients.
The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
Accreditation StatementIn support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. | |
American Medical Association (AMA)The University of Wisconsin–Madison ICEP designates this live online activity for a maximum of 8.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. American Nurses Credentialing Center (ANCC)The University of Wisconsin–Madison ICEP designates this virtual live activity for a maximum of 8.25 ANCC contact hours. | |
American Academy of Physician Assistants (AAPA)The University of Wisconsin–Madison ICEP has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 8.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. | |
Continuing Education Units (CEUs)The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for .825 CEUs or 8.25 hours. Wisconsin Medical Examining Board Opioid CMEThis course has been approved by the Wisconsin Medical Examining Board as meeting the requirements for a continuing education course on the responsible opioid prescribing guidelines per Med 13.03(3) of the Wisconsin Administrative Code. Course title: Substance Use Disorders Management Boot Camp In-Person Workshops (September 15-16, 2022) |
Available Credit
- 8.25 AAPA Category 1 CME
- 2.50 Wisconsin Responsible Opioid Prescribing Credit
- 8.25 AMA PRA Category 1 Credit™
- 2.50 Wisconsin Responsible Opioid Prescribing Credit
- 8.25 ANCC Contact Hours
- 2.50 Wisconsin Responsible Opioid Prescribing Credit
- 8.25 University of Wisconsin–Madison Continuing Education Hours
- 2.25 Approved for AMA PRA Category 1 Credit™
- 6.50 Wisconsin Responsible Opioid Prescribing Credit
Learners will receive registration links on Sunday, May 5. Links will be emailed to the same email you used to register.
QUESTIONS ABOUT EVENT & VENUE
Email Kathleen Maher kathleen.maher@fammed.wisc.edu
QUESTIONS REGARDING REGISTRATION
Email help@icep.wisc.edu.
PROGRAM CHANGES
Emergency situations occasionally occur and may necessitate topic or speaker changes. The University of Wisconsin School of Medicine and Public Health and the University of Wisconsin–Madison ICEP reserve the right to alter or substitute a topic or speaker without prior notification.
ACCESSIBILITY
The University of Wisconsin provides equal opportunities in employment and programming, including Title IX requirements. The University of Wisconsin fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us at help@icep.wisc.edu
FOR FURTHER INFORMATION
For additional questions about the conference, including accessibility requests, please contact: